1,250
Participants
Start Date
December 10, 2021
Primary Completion Date
June 30, 2022
Study Completion Date
August 31, 2022
(OraQuick® HCV Self-Test
The OraQuick® HCV Self-Test is a lateral flow rapid diagnostic that can detect anti-HCV antibodies in oral fluid. Instructions for Use (IFU) for OraQuick® HCV Rapid Antibody Self-Test have been developed in Georgian for the previous 2 studies conducted in Georgia using the OraQuick® HCV Rapid Antibody Self-Test. The IFU has been optimized taking in the feedback on the IFU resulting from the aforementioned studies. As this HCV test is not approved for self-test use in Georgia, all tests will be labelled as Research Use Only (RUO) and test results will not be used for patient management.
RECRUITING
Center for Information and Counselling on Reproductive Health-Tanadgoma, Batumi
RECRUITING
Equality Movement, Batumi
RECRUITING
Imedi Harm Reduction Site, Batumi
RECRUITING
Center for Information and Counselling on Reproductive Health-Tanadgoma, Tbilisi
RECRUITING
Equality Movement, Tbilisi
RECRUITING
Tbilisi New Way Harm Reduction Site, Tbilisi
Collaborators (1)
National Center for Disease control and Public Health
OTHER_GOV
Batumi Imedi Harm Reduction Site
UNKNOWN
Equality Movement
UNKNOWN
Center for Information and Counseling on Reproductive Health - Tanadgoma
OTHER
Tbilisi New Way Harm Reduction Site
UNKNOWN
Foundation for Innovative New Diagnostics, Switzerland
OTHER